Helius Medical Technologies, Inc. (HSDT)
USD 0.4
(-2.44%)
USD 0.4
(-2.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -12.42 Million USD | 16.87% |
| 2022 | -14.75 Million USD | 18.65% |
| 2021 | -18.14 Million USD | -26.11% |
| 2020 | -14.38 Million USD | 40.05% |
| 2019 | -23.99 Million USD | 10.04% |
| 2018 | -26.67 Million USD | -16.72% |
| 2017 | -22.85 Million USD | -120.29% |
| 2016 | -10.37 Million USD | -17.03% |
| 2015 | -8.86 Million USD | -730.58% |
| 2014 | -1.06 Million USD | 87.47% |
| 2013 | -8.51 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.41 Million USD | -52.09% |
| 2024 Q2 | -3.27 Million USD | 4.27% |
| 2023 Q2 | -3.21 Million USD | 15.51% |
| 2023 Q1 | -3.81 Million USD | -42.75% |
| 2023 Q4 | -2.24 Million USD | 28.77% |
| 2023 Q3 | -3.15 Million USD | 2.05% |
| 2023 FY | -12.26 Million USD | 16.87% |
| 2022 Q3 | -4.09 Million USD | -19.42% |
| 2022 Q1 | -4.56 Million USD | -11.26% |
| 2022 Q4 | -2.66 Million USD | 34.84% |
| 2022 FY | -14.75 Million USD | 18.65% |
| 2022 Q2 | -3.43 Million USD | 24.85% |
| 2021 Q3 | -4.37 Million USD | 29.08% |
| 2021 FY | -18.14 Million USD | -26.11% |
| 2021 Q1 | -3.5 Million USD | -16.62% |
| 2021 Q2 | -6.16 Million USD | -76.12% |
| 2021 Q4 | -4.1 Million USD | 6.2% |
| 2020 Q4 | -3 Million USD | 17.98% |
| 2020 Q1 | -4 Million USD | 28.85% |
| 2020 Q2 | -3.72 Million USD | 7.0% |
| 2020 Q3 | -3.66 Million USD | 1.67% |
| 2020 FY | -14.38 Million USD | 40.05% |
| 2019 Q1 | -6.82 Million USD | -29.6% |
| 2019 FY | -23.99 Million USD | 10.04% |
| 2019 Q4 | -5.62 Million USD | 1.94% |
| 2019 Q3 | -5.73 Million USD | 1.34% |
| 2019 Q2 | -5.81 Million USD | 14.76% |
| 2018 Q3 | -4.89 Million USD | 58.58% |
| 2018 FY | -26.67 Million USD | -16.72% |
| 2018 Q2 | -11.8 Million USD | -150.31% |
| 2018 Q1 | -4.71 Million USD | 19.64% |
| 2018 Q4 | -5.26 Million USD | -7.63% |
| 2017 FY | -22.85 Million USD | -120.29% |
| 2017 Q1 | -5.03 Million USD | -156.29% |
| 2017 Q2 | -5.98 Million USD | -18.8% |
| 2017 Q3 | -5.97 Million USD | 0.17% |
| 2017 Q4 | -5.87 Million USD | 1.68% |
| 2016 Q2 | -2.1 Million USD | 27.83% |
| 2016 FY | -10.37 Million USD | -17.03% |
| 2016 Q1 | -2.91 Million USD | -2.63% |
| 2016 Q4 | -1.96 Million USD | 42.08% |
| 2016 Q3 | -3.39 Million USD | -61.16% |
| 2015 Q1 | 4.2 Million USD | 202.2% |
| 2015 Q4 | -2.84 Million USD | -167.58% |
| 2015 FY | -8.86 Million USD | -730.58% |
| 2015 Q3 | -1.06 Million USD | 62.55% |
| 2015 Q2 | -2.83 Million USD | -167.41% |
| 2014 Q2 | -1.74 Million USD | -190.05% |
| 2014 Q1 | -602.36 Thousand USD | -80.54% |
| 2014 Q3 | -2.76 Million USD | -58.39% |
| 2014 Q4 | -4.11 Million USD | -48.7% |
| 2014 FY | -1.06 Million USD | 87.47% |
| 2013 Q2 | -63.98 Thousand USD | 0.0% |
| 2013 FY | -8.51 Million USD | 0.0% |
| 2013 Q3 | -67.28 Thousand USD | -5.15% |
| 2013 Q4 | -333.65 Thousand USD | -395.92% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 13.46% |
| Cerus Corporation | -30.05 Million USD | 58.646% |
| OrthoPediatrics Corp. | -25.76 Million USD | 51.766% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -17.01% |
| Talis Biomedical Corporation | -66.81 Million USD | 81.399% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 28.145% |
| Inogen, Inc. | -109.38 Million USD | 88.638% |
| Spectral AI, Inc. | -12.98 Million USD | 4.282% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 80.143% |
| CVRx, Inc. | -43.1 Million USD | 71.167% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -252.268% |
| Orthofix Medical Inc. | -139.11 Million USD | 91.066% |
| Venus Concept Inc. | -28.3 Million USD | 56.099% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 76.997% |
| Bioventus Inc. | -81.72 Million USD | 84.793% |
| BrainsWay Ltd. | -4.92 Million USD | -152.243% |
| Envoy Medical, Inc. | -18.37 Million USD | 32.35% |
| electroCore, Inc. | -18.8 Million USD | 33.911% |
| IceCure Medical Ltd | -15.57 Million USD | 20.211% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 74.366% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 28.029% |
| MaxCyte, Inc. | -48.29 Million USD | 74.269% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -3.954% |
| Nexalin Technology, Inc. | -5.69 Million USD | -118.177% |
| PAVmed Inc | -68.79 Million USD | 81.935% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 78.028% |
| RxSight, Inc. | -50.08 Million USD | 75.186% |
| Sight Sciences, Inc. | -57.27 Million USD | 78.301% |
| SI-BONE, Inc. | -46.93 Million USD | 73.519% |
| TELA Bio, Inc. | -44.07 Million USD | 71.803% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 77.049% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 75.834% |
| LivaNova PLC | -68.49 Million USD | 81.856% |
| 908 Devices Inc. | -42.75 Million USD | 70.934% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 92.833% |
| Nemaura Medical Inc. | -9.59 Million USD | -29.523% |
| NeuroPace, Inc. | -27.17 Million USD | 54.265% |
| LENSAR, Inc. | -12.22 Million USD | -1.627% |
| Apyx Medical Corporation | -17.25 Million USD | 27.991% |
| Cutera, Inc. | -156.23 Million USD | 92.045% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -44.444% |
| BioSig Technologies, Inc. | -28.51 Million USD | 56.411% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 85.819% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 44.632% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 111.144% |
| Axonics, Inc. | -26.05 Million USD | 52.305% |
| Outset Medical, Inc. | -169.77 Million USD | 92.68% |
| IRIDEX Corporation | -10 Million USD | -24.193% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 88.616% |
| IRadimed Corporation | 20.03 Million USD | 162.03% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -50.734% |
| INVO Bioscience, Inc. | -6.76 Million USD | -83.652% |
| Telesis Bio, Inc. | -35.15 Million USD | 64.643% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 186.727% |
| Varex Imaging Corporation | 32.1 Million USD | 138.717% |
| Quipt Home Medical Corp. | 3.91 Million USD | 417.122% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -2.431% |
| Pulmonx Corporation | -61.93 Million USD | 79.934% |
| Dynatronics Corporation | -2.27 Million USD | -446.755% |
| Modular Medical, Inc. | -17.52 Million USD | 29.1% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 15.103% |
| Semler Scientific, Inc. | 22.25 Million USD | 155.841% |
| InMode Ltd. | 195.66 Million USD | 106.352% |
| Bruker Corporation | 436.9 Million USD | 102.845% |
| Cytosorbents Corporation | -31.2 Million USD | 60.178% |
| DexCom, Inc. | 597.7 Million USD | 102.079% |
| Align Technology, Inc. | 643.33 Million USD | 101.932% |
| Viveve Medical, Inc. | -21.55 Million USD | 42.337% |
| ZimVie Inc. | -30.93 Million USD | 59.831% |
| Movano Inc. | -29.69 Million USD | 58.141% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 55.367% |
| Nexalin Technology, Inc. | -5.69 Million USD | -118.177% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -252.268% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 94.671% |
| Profound Medical Corp. | -28.61 Million USD | 56.57% |
| Insulet Corporation | 220 Million USD | 105.649% |
| enVVeno Medical Corporation | -25.23 Million USD | 50.757% |
| Surmodics, Inc. | -5.64 Million USD | -120.159% |
| iCAD, Inc. | -7.68 Million USD | -61.634% |
| Nuwellis, Inc. | -17.63 Million USD | 29.507% |
| Biotricity, Inc. | -8.82 Million USD | -40.775% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 90.07% |
| Aethlon Medical, Inc. | -12.63 Million USD | 1.651% |
| InspireMD, Inc. | -21.14 Million USD | 41.219% |
| PAVmed Inc. | -68.79 Million USD | 81.935% |
| BIOLASE, Inc. | -17.93 Million USD | 30.713% |
| Beyond Air, Inc. | -63 Million USD | 80.275% |
| FONAR Corporation | 16.53 Million USD | 175.16% |
| AxoGen, Inc. | -21.46 Million USD | 42.093% |
| Vivani Medical, Inc. | -26.96 Million USD | 53.911% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 168.888% |
| Inari Medical, Inc. | -14.03 Million USD | 11.431% |
| UFP Technologies, Inc. | 57.66 Million USD | 121.552% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -152.212% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -97.089% |
| Tenon Medical, Inc. | -15.72 Million USD | 20.977% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -66.283% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 70.899% |
| AdaptHealth Corp. | -598.4 Million USD | 97.923% |
| Sintx Technologies, Inc. | -13.35 Million USD | 6.962% |
| NanoVibronix, Inc. | -3.43 Million USD | -261.7% |
| Quanterix Corporation | -49.7 Million USD | 74.994% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -2.431% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -3153.403% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 96.284% |
| TransMedics Group, Inc. | -28.72 Million USD | 56.738% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 47.366% |
| NeuroMetrix, Inc. | -7.15 Million USD | -73.781% |
| Hyperfine, Inc. | -48.11 Million USD | 74.17% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 80.888% |
| Biomerica, Inc. | -6.36 Million USD | -95.194% |
| Bone Biologics Corporation | -9.42 Million USD | -31.816% |
| AVITA Medical, Inc. | -40.4 Million USD | 69.239% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -20.529% |
| Silk Road Medical, Inc | -59.27 Million USD | 79.032% |